EMFO LLC’s AbbVie ABBV Stock Holding History

EMFO LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$314K	Hold	1,830	–	–	0.28%	64
2024 Q1	$333K	Hold	1,830	–	–	0.31%	67
2023 Q4	$284K	Hold	1,830	–	–	0.26%	79
2023 Q3	$273K	Hold	1,830	–	–	0.26%	74
2023 Q2	$247K	Sell	1,830 -2,500	-58%	-$367K	0.22%	84
2023 Q1	$690K	Hold	4,330	–	–	0.65%	44
2022 Q4	$700K	Hold	4,330	–	–	0.7%	40
2022 Q3	$581K	Hold	4,330	–	–	0.55%	49
2022 Q2	$663K	Hold	4,330	–	–	0.67%	41
2022 Q1	$702K	Sell	4,330 -600	-12%	-$87.2K	0.64%	35
2021 Q4	$668K	Hold	4,930	–	–	0.59%	43
2021 Q3	$532K	Hold	4,930	–	–	0.47%	50
2021 Q2	$555K	Buy	+4,930	New	+$555K	0.49%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EMFO LLC's ABBV Position: Q2 2024 in Review

EMFO LLC held its AbbVie (ABBV) position steady in Q2 2024 at 1,830 shares worth $314K. The position accounts for 0.28% of the portfolio, ranked #64.

EMFO LLC first reported a position in ABBV in Q2 2021 and has held it in 13 quarters since. The position peaked at $702K in Q1 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

EMFO LLC held 1,830 shares of AbbVie worth $314K as of Q2 2024.
EMFO LLC left its AbbVie share count unchanged in Q2 2024.
AbbVie made up 0.28% of EMFO LLC's portfolio in Q2 2024, its #64 holding.
EMFO LLC first reported a position in AbbVie in Q2 2021 and has held it in 13 quarters since.
EMFO LLC's AbbVie position peaked at $702K in Q1 2022.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.